1. Referans 1. Akduman AT, Özerkan K, Zik B, et al. (2014): Effect of tamoxifen on ovarian reserve: A randomized controlled assessor-blind trial in a mouse model. J Turk Ger Gynecol Assoc, 15, 228–232.Referans 2. Akkaya OO, Altunbas K, Yagcı A (2017): Effects of methoxychlor on IGF-1 signaling pathway in rat ovary. Biotech Histochem, 92, 230-242. Referans 3. Armstrong DG, Webb R (1997): Ovarian follicular dominance: the role of intraovarian growth factors and novel proteins. Rev Reprod, 2, 139–146.Referans 4. Armstrong DG, Gutierrez CG, Baxter G, et al. (2000): Expression of mRNA encoding IGF-1, IGF-1I and type 1 IGF receptor in bovine ovarian follicles. J Endocrinol, 165, 101.113. Referans 5. Baumgarten SC, Convissar SM, Fierro MA, et al. (2014): IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human cumulus granulosa cells. J Clin Endocrinol Metab, 99, 2995–3004.Referans 6. Cara JF, Rosenfield RL (1988): Insulin-like growth factor I and ınsulin potentiate luteinizing hormone-ınduced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology, 123, 733-739. Referans 7. Cohen I, Figer A, Tepper R, et al. (1999): Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen treated and nontreated breast cancer patients. Gynecol Oncol, 72, 202-207.Referans 8. Crossman G (1937): A modification of Mallory’s connective tissue stain with a discussion of the principles involved. Anat Rec, 69, 33-38.Referans 9. Cruickshank J, Grossman DI, Peng RK, et al. (2005): Spatial distribution of growth hormone receptor, insulin-like growth factor-I receptor and apoptotic chondrocytes during growth plate development. J Endocrinol, 184, 543-553. Referans 10. Ergin K, Gursoy E, Baġımoğlu-Koca Y, et al. (2008): Immunohistochemical detection of insulin-like growth factor-I, transforming growth factor-b2, basic fibroblast growth factor and epidermal growth factor-receptor expression in developing rat ovary. Cytokine, 43, 209-214.Referans 11. Fu Z, Noguchi T, Kato H (2001): Vitamin a deficiency reduces insulin-like growth factor (IGF)-I gene expression and increases IGF-1 receptor and insulin receptor gene expression in tissues of japanese quail (coturnix coturnix japonica). J Nutr, 131, 1189-1194.Referans 12. Guthrie HD, Garrett WM, Cooper BS (1998): Follicle-stimulating hormone and insulin-like growth factor-I attenuate apoptosis in cultured porcine granulosa cells. Biol Reprod, 58, 390-396. Referans 13. Higgins MJ, Baselga J (2011): Targeted therapies for breast cancer. Journal Clin Invest, 121, 3797–3803. Referans 14. Hu CL, Cowan RG, Harman RM, et al. (2004): Cell cycle progression and activation of akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells. Mol Endocrinol, 18, 326-338.Referans 15. Kwintkiewicz J, Giudice LC (2009): The interplay of insulin-like growth factors, gonadotropins, and endocrine disruptors in ovarian follicular development and function. Semin Reprod Med, 27, 43-51. Referans 16. Luigi LD, Conti FG, Casini A (1997): Growth hormone and insulin-like growth factor I responses to moderate submaximal acute physical exercise in man: effects of octreotide, a somatostatin analogue, administration. Int J Sports Med, 18, 257–263. Referans 17. Macgregor JI, Jordan C (1998): Basic guide to the mechanisms of antiestrogens. Pharmacol Rev, 50, 151–196.Referans 18. Mahran YF, El-Demerdash E, Nada AS, et al. (2013): Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: Impact on insulin-like growth factor 1. Endocrinology, 154, 3888-3899.Referans 19. Mazerbourg S, Bondy CA, Zhou J, et al. (2003): The insulin-like growth factor system: a key determinant role in the growth and selection of ovarian follicles? a comparative species study. Reprod Domest Anim, 38, 247-258.Referans 20. Monget P, Fabre S, Mulsant P, et al. (2002): Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol, 23, 139-154. Referans 21. Monniaux D, Pisselet C (1992): Control of proliferation and differentiation of ovine granulosa cells by insulin-like growth factor-I and follicle-stimulating hormone in vitro. Biol Reprod, 46, 109-119.Referans 22. Mourits MJE, Vries EGE, Willemse PHB, et al. (1999): Ovarian cysts in women receiving tamoxifen for breast cancer. Br J Cancer, 79, 1761–1764.Referans 23. Oktay K, Schenken RS, Nelson JF (1995): Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat. Biol Reprod, 53, 295–301. Referans 24. O'Regan RM, Cisneros A, England GM, et al. (1998): Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth. J Natl Cancer Inst, 90, 1552-1558. Referans 25. Pasqualini JR, Sumida C, Giambiagi N (1998): Pharmacodynamic and biological effects of anti-estrogens in different models. J Steroid Biochem, 31, 613-643.Referans 26. Perks CM, Peters AR, Wathes DC (1999): Follicular and luteal expression of insulin-like growth factors I and II and the type 1 IGF receptor in the bovine ovary. J Reprod Fertil, 116, 157-165.Referans 27. Pollak MN, Huynh HT, Lefebvre SP (1992): Tamoxifen reduces serum insulin-like growth factor I (IGF-1). Breast Cancer Res Treat, 22, 91-100.Referans 28. Qu J, Godin PA, Nisolle M, et al. (2000): Expression of receptors for insulin-like growth factor-I and transforming growth factor-β in human follicles. Mol Hum Reprod, 6, 137-145. Referans 29. Quirk SM, Cowan RG, Harman RM, et al. (2004): Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci, 82, 40–52.Referans 30. Ramachandran C, Khatib Z, Petkarou A, et al. (2004): Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. J Neurooncol, 67, 19-28. Referans 31. Rzepczynska IJ, Piotrowski PC, Wong DH, et al. (2009): Role of isoprenylation in Simvastatin-Induced inhibition of ovarian theca-interstitial growth in the rat. Biol Reprod, 81, 850–855.Referans 32. Sherman BM, Chapler FK, Crickard K, et al. (1979): Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women. J Clin Invest, 64, 398–404.Referans 33. Shushan A, Peretz T, Uziely B, et al. (1996): Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol, 174, 141–144. Referans 34. Spicer LJ, Chamberlain CS (1998): Influence of cortisol on insulin- and insulin-like growth factor 1 (IGF-1)-induced steroid production and on IGF-1 receptors in cultured bovine granulosa cells and thecal cells. Endocrine, 9, 153–161.Referans 35. Terada S, Uchide K, Suzuki N (1993): A follicular cyst during tamoksifen therapy in a premenopausal breast cancer woman. Gynecol Obstet Invest, 35, 62-64.Referans 36. Thissen JP, Ketelslegers JM, Underwood LE (1994): Nutritional regulation of the insulin-like growth factors. Endocr Rev, 15, 80-163. Referans 37. Ting AY, Kimler BF, Fabian CJ, et al. (2008): Tamoxifen prevents premalignant changes of breast but not ovarian cancer in rats at high risk for both diseases. Cancer Prev Res, (Phila) 1, 546–553. Referans 38. Ting AY, Petroff BK (2010): Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat. J Assist Reprod Genet, 27, 591–597.Referans 39. Toda K, Miyaura C, Okada T, et al. (2002): Dietary bisphenol a prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (Cyp19). Eur J Biochem, 269, 2214–2222. Referans 40. Tsujioka S, Ban Y, Wise LD, et al. (2009): Collaborative work on evaluation of ovarian toxicity. 3) Effects of 2- or 4- week repeated dose toxicity and fertility studies with tamoksifen in female rats. J Toxicol Sci, 34, 43-51. Referans 41. Tucker MJ, Adam HK, Patterson JS (1984): Tamoxifen. 125-161. In: Laurence DR, McLean AEM, Wetherall M (eds), Safety Testing of New Drugs, Laboratory Predictions and Clinical Performance Academic. Press, London. Referans 42. Wandji SA, Wood TL, Crawford J, et al. (1998): Expression of mouse ovarian insulin growth factor system components during follicular development and atresia. Endocrinology, 139, 5205–5214.Referans 43. Werner H, Shen-Orr Z, Stannard B, et al. (1990): Experimental diabetes ıncreases ınsulinlike growth factor I and II receptor concentration and gene expression in kidney. Diabetes, 39, 1490-1497. Referans 44. Zhou J, Chin E, Bondy C (1991): Cellular Pattern of insulin-like factor-I (IGF-1) and IGF-1 receptor gene expression in the developing and mature ovarian follicle. Endocrinology, 129, 3281-3288. Referans 45. Zhou P, Baumgarten SC, Wu Y, et al. (2013): IGF-1 signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells. Mol Endocrinol, 27, 511–523.